Dr. Catriona Jamieson.Sanford Consortium for Regenerative Medicine.Stem cell laboratory.Moores Cancer Center.

Welcome to the Division of Regenerative Medicine

We are dedicated to delivering superb state-of-the-art clinical care and bringing the advancement of scientific research in regenerative medicine to the forefront of public and scientific spheres both locally and globally. We study vaccines, therapies, diagnostics, cures and research technologies to relieve human suffering from chronic disease and injury.

News

Recent news and advances:

Registration is now open for the Division of Regenerative Medicine 3rd Annual Research Symposium on March 10, 2017.
Register for the Symposium

Dr. Jamieson's project  Identification of Novel RNA Editing Biomarkers of Human Leukemia Stem Cell Generation highlighted by the awarding agency, Congressionally Directed Medical Research Programs. October 28, 2016.  CDRMP Press Release

Dr. Jamieson was a conference organizer and discussion moderator at the 28th Usha Mahajani Symposium for Molecular Medicine, September 9, 2016.
Brochure

Meet Dan Kaufman, MD, PhD

Dan Kaufman, MD, PhDDan Kaufman, MD, PhD, has joined the Division of Regenerative Medicine as Professor of Medicine and Director of Cell Therapy.

The Kaufman laboratory uses human pluripotent stem cells to understand the development of blood cells and related mesodermal cell populations. The aim is to use human pluripotent stem cells as a resource for new clinical applications for treatment of relapsed/refractory cancers -- both hematologic malignancies and solid tumors.

Dr. Kaufman also provides clinical care for patients with hematological malignancies, with special interest in blood and marrow transplantation (BMT) and immune therapies.

 

Meet Robert Signer, PhD

Robert Signer, PhDRobert Signer, PhD, has joined the Division of Regenerative Medicine as Assistant Professor of Medicine.

In the Signer Laboratory, the central goal is to determine how cell-type specific differences in protein synthesis promote tissue regeneration and suppress the development of cancer. 

The lab is working to discover how mechanisms of translational control regulate normal and diseased stem cell function. By doing so, they expect to improve their ability to harness the regenerative potential of stem cells and identify therapeutic opportunities to treat diseases.